Frequency of TERT promoter mutations in human cancers

Vinagre, João, Almeida, Ana, Pópulo, Helena, Batista, Rui, Lyra, Joana, Pinto, Vasco, Coelho, Ricardo, Celestino, Ricardo +16 more·2013·Nature Communications

DOI 10.1038/ncomms3185

Cited by (886)

Items 301–400 of 886

The genetic duet of BRAF V600E and TERT promoter mutations predicts the poor curative effect of radioiodine therapy in papillary thyroid cancer
Jingjia Cao, Xiaolu Zhu, Yaru Sun, Xiao Li, Canhua Yun, Wei Zhang · 2022 · European Journal of Nuclear Medicine and Molecular Imaging
Coexistence of TERT Promoter and BRAF Mutations in Papillary Thyroid Carcinoma: Added Value in Patient Prognosis?
Miguel Melo, Adriana Gaspar da Rocha, João Vinagre, Manuel A. Sobrinho-Simões, Paula Soares · 2015 · Journal of Clinical Oncology
Reactivation of telomerase reverse transcriptase expression in cancer: the role of TERT promoter mutations
Maria Lina Tornesello, Andrea Cerasuolo, Noemy Starita, Sara Amiranda, Patrizia Bonelli, Franca Maria Tuccillo, Franco M. Buonaguro, Luigi Buonaguro, Anna Lucia Tornesello · 2023 · Frontiers in Cell and Developmental Biology
Telomere-Regulating Genes and the Telomere Interactome in Familial Cancers
Carla Daniela Robles‐Espinoza, Martin Del Castillo Velasco‐Herrera, Nicholas K. Hayward, David J. Adams · 2014 · Molecular Cancer Research
Expression of the human telomerase reverse transcriptase gene is modulated by quadruplex formation in its first exon due to DNA methylation
Pei‐Tzu Li, Zifu Wang, I-Te Chu, Yen-Min Kuan, Minghao Li, Mu-Ching Huang, Pei-Chi Chiang, Ta‐Chau Chang, Chin‐Tin Chen · 2017 · Journal of Biological Chemistry
A method to reduce ancestry related germline false positives in tumor only somatic variant calling
Rebecca F. Halperin, John David Carpten, Zarko Manojlovic, Jessica Aldrich, Jonathan J. Keats, Sara Ann Byron, Winnie S. Liang, Megan Russell, Daniel Enríquez, Ana M. Claasen et al. · 2017 · BMC Medical Genomics
ETS Factor ETV5 Activates the Mutant Telomerase Reverse Transcriptase Promoter in Thyroid Cancer
Martyn Bullock, Grace Lim, Ying Zhu, Helena Åberg, Sergey Kurdyukov, Roderick John Clifton-Bligh · 2019 · Thyroid
TERT, a promoter of CNS malignancies
Bhuvic Patel, Rukayat Taiwo, Albert H. Kim, Gavin P. Dunn · 2020 · Neuro-Oncology Advances
Mutational Landscapes of Smoking-Related Cancers in Caucasians and African Americans: Precision Oncology Perspectives at Wake Forest Baptist Comprehensive Cancer Center
Ville Kytölä, Ümit Topaloĝlu, Lance David Miller, Rhonda Lynn Bitting, Michael Moses Goodman, Ralph B. D`Agostino, Rodwige J. Desnoyers, Carol A. Albright, George Yacoub, Shadi A. Qasem et al. · 2017 · Theranostics
Challenges in identifying cancer genes by analysis of exome sequencing data
Matan Hofree, Hannah K. Carter, Jason F. Kreisberg, Sourav Bandyopadhyay, Paul S. Mischel, Stephen Henry Friend, Trey Ideker · 2016 · Nature Communications
TERT promoter mutations in thyroid cancer
Michiko Matsuse, Norisato Mitsutake · 2023 · Endocrine Journal
Low frequency of TERT promoter mutations in a large cohort of gallbladder and gastric cancers
Yiping Qu, Lei Shi, Dan Wang, Bingfei Zhang, Qi Yang, Meiju Ji, Bingyin Shi, Peng Hou · 2013 · International Journal of Cancer
Molecular alterations in endometrial and ovarian clear cell carcinomas: clinical impacts of telomerase reverse transcriptase promoter mutation
Hsien‐Neng Huang, Ying‐Cheng Chiang, Wen‐Fang Cheng, Chi‐An Chen, Ming-Chieh Lin, Kuan‐Ting Kuo · 2014 · Modern Pathology
Beyond the exome: the role of non-coding somatic mutations in cancer
Scott William Piraino, Simon J. Furney · 2015 · Annals of Oncology
CRABP1, C1QL1 and LCN2 are biomarkers of differentiated thyroid carcinoma, and predict extrathyroidal extension
Ricardo Celestino, Torfinn Nome, Ana Pestana, Andreas Hoff, A. Pedro Gonçalves, Luı́sa Pereira, Bruno Cavadas, Catarina Eloy, Trine Bjøro, Manuel A. Sobrinho-Simões et al. · 2018 · BMC Cancer
Molecular Pathology of Non-familial Follicular Epithelial–Derived Thyroid Cancer in Adults: From RAS/BRAF-like Tumor Designations to Molecular Risk Stratification
Paula Soares, Antónia Afonso Póvoa, Miguel Melo, João Vinagre, Valdemar Máximo, Catarina Eloy, José Cameselle‐Teijeiro, Manuel A. Sobrinho-Simões · 2021 · Endocrine Pathology
RETRACTED ARTICLE: Telomerase gene therapy: a remission toward cancer
Sameer Quazi · 2022 · Medical Oncology · Retracted
Uncommon TERT Promoter Mutations in Pediatric Thyroid Cancer
Ali Saeed Alzahrani, Ebtesam Qasem, Avaniyapuram Kannan Murugan, Hindi Al‐Hindi, Dania Alkhafaji, Mai Almohanna, Mingzhao Xing, Doha S. Alhomaidah, Meshael M. Alswailem · 2015 · Thyroid
Targeting hTERT Promoter G-Quadruplex DNA Structures with Small-Molecule Ligand to Downregulate hTERT Expression for Triple-Negative Breast Cancer Therapy
Wei Sing Long, Yaoxun Zeng, Bo‐Xin Zheng, Yubo Li, Yakun Wang, Ka‐Hin Chan, Mengting She, Yu‐Jing Lu, Chunyang Cao, Wing‐Leung Wong · 2024 · Journal of Medicinal Chemistry
Insights from human genetic studies of lung and organ fibrosis
Christine Kim Garcia · 2018 · Journal of Clinical Investigation
Telomeres and Cancer
Hueng‐Chuen Fan, Fung-Wei Chang, Jeng‐Dau Tsai, Kao‐Min Lin, Chuan‐Mu Chen, Shinn‐Zong Lin, Ching-Ann Liu, Horng‐Jyh Harn · 2021 · Life
The Subventricular Zone in Glioblastoma: Genesis, Maintenance, and Modeling
Jamison Beiriger, Ahmed Habib, Nicolina Jovanovich, Chowdari V. Kodavali, Lincoln Edwards, Nduka Amankulor, Pascal Olivier Zinn · 2022 · Frontiers in Oncology
Mechanistic Insights of Thyroid Cancer Progression
Luis Javier Leandro-Garcia, Iñigo Landa · 2023 · Endocrinology
Cell populations can use aneuploidy to survive telomerase insufficiency
Caroline Millet, Darya Ausiannikava, Thierry Le Bihan, Sander Granneman, Svetlana Makovets · 2015 · Nature Communications
Telomerase reverse transcriptase promoter mutations in hepatitis B virus-associated hepatocellular carcinoma
Xunjun Yang, Xiuchan Guo, Yao Chen, Guorong Chen, Yin Ma, Kate Huang, Yuning Zhang, Qiongya Zhao, Cheryl Ann Winkler, Ping An et al. · 2016 · Oncotarget
Non-coding cancer driver candidates identified with a sample- and position-specific model of the somatic mutation rate
Malene Juul, Johanna Bertl, Qianyun Guo, Morten Muhlig Nielsen, Michał Świtnicki, Henrik Hornshøj, Tobias Lynge Madsen, Asger Hobolth, Jakob Skou Pedersen · 2017 · eLife
mTOR Pathway in Papillary Thyroid Carcinoma: Different Contributions of mTORC1 and mTORC2 Complexes for Tumor Behavior and SLC5A5 mRNA Expression
Catarina Tavares, Catarina Eloy, Miguel Melo, Adriana Gaspar da Rocha, Ana Pestana, Rui Batısta, Luciana Bueno Ferreira, Elisabete Rios, Manuel A. Sobrinho-Simões, Paula Soares · 2018 · International Journal of Molecular Sciences
Genetic Determinants for Prediction of Outcome of Patients with Papillary Thyroid Carcinoma
Antónia Afonso Póvoa, Elisabete Teixeira, Maria Rosa Bella-Cueto, Rui Batısta, Ana Pestana, Miguel Melo, Thalita G. Alves, Mafalda Pinto, Manuel A. Sobrinho-Simões, Jorge Maciel et al. · 2021 · Cancers
Functional evaluation of TERT-CLPTM1L genetic variants associated with susceptibility of papillary thyroid carcinoma
Minghua Ge, Meng Shi, Changming An, Wenjun Yang, Xilin Nie, Jian Zhang, Zheng Lv, Jinliang Li, Liqing Zhou, Zhongli Du et al. · 2016 · Scientific Reports
A comprehensive review on novel targeted therapy methods and nanotechnology-based gene delivery systems in melanoma
Azadeh Rahimi, Yasaman Esmaeili, Nasim Dana, Arezou Dabiri, Ilnaz Rahimmanesh, Setareh Jandaghian, Golnaz Vaseghi, Laleh Shariati, Ali Zarrabi, Shaghayegh Haghjooy Javanmard et al. · 2023 · European Journal of Pharmaceutical Sciences
Genome-wide profiling identifies the THYT1 signature as a distinctive feature of widely metastatic Papillary Thyroid Carcinomas
Greta Gandolfi, Moira Ragazzi, Dario de Biase, Michela Visani, Eleonora Zanetti, Federica Torricelli, Valentina Sancisi, Mila Gugnoni, Gloria Manzotti, Luca Braglia et al. · 2017 · Oncotarget
Coexistence of TERT Promoter Mutations and the BRAF V600E Alteration and Its Impact on Histopathological Features of Papillary Thyroid Carcinoma in a Selected Series of Polish Patients
Dagmara Rusinek, Aleksandra Pfeifer, Jolanta Krajewska, Małgorzata Oczko‐Wojciechowska, Daria Handkiewicz-Junak, Agnieszka Pawlaczek, Jadwiga Żebracka‐Gala, Małgorzata Kowalska, Renata Cyplinska, Ewa Zembala‐Nożyńska et al. · 2018 · International Journal of Molecular Sciences
Telomerase and Telomeres in Endometrial Cancer
Rafah Alnafakh, Meera Adishesh, Lucy Button, Gabriele Christine Saretzki, Dharani Kosala Hapangama · 2019 · Frontiers in Oncology
TERT Promoter Mutation as a Potential Predictive Biomarker in BCG-Treated Bladder Cancer Patients
Rui Batısta, Luís Lima, João Vinagre, Vasco Sá Pinto, Joana Lyra, Valdemar Máximo, Lúcio Lara Santos, Paula Soares · 2020 · International Journal of Molecular Sciences
TERT Promoter Mutations and the 8th Edition TNM Classification in Predicting the Survival of Thyroid Cancer Patients
Jun Tae Park, Sungjoo Lee, Kyunga Kim, Hyunju Park, Chang‐Seok Ki, Young Lyun Oh, Jung Hee Shin, Jee Soo Kim, Sun Wook Kim, Jae Hoon Chung et al. · 2021 · Cancers
Development and Characterization of Six New Human Papillary Thyroid Carcinoma Cell Lines
Ying C. Henderson, Soon‐Hyun Ahn, Junsun Ryu, Yunyun Chen, Michelle D. Williams, Adel K. El‐Naggar, Mihai Gagea, Rebecca E. Schweppe, Bryan R. Haugen, Stephen Yenzen Lai et al. · 2014 · The Journal of Clinical Endocrinology & Metabolism
Recurrent TERT promoter mutations in non-small cell lung cancers
Xiao Ma, Ranxia Gong, Rui Wang, Yunjian Pan, Deng Cai, Bin Pan, Yuan Li, Jiaqing Xiang, Hecheng Li, Jie Zhang et al. · 2014 · Lung Cancer
Thyroid Cancer Bone Metastasis
Jessica D. Kondraciuk, Samuel L. Rice, Xiaosun Zhou, Karem Gharzeddine, Andrea Knežević, Daniel Eidelberg Spratt, Mona M. Sabra, Steven M. Larson, Ravinder K. Grewal, Joseph R. Osborne · 2019 · Clinical Nuclear Medicine
Diverse regulatory manners of human telomerase reverse transcriptase
Mengmeng Jie, Xing Chang, Shuo Zeng, Liu C, Guobin Liao, Yaran Wu, Chunhua Liu, Chang-jiang Hu, Shiming Yang, Xin‐Zhe Li · 2019 · Cell Communication and Signaling
Inflammatory Cytokines and ctDNA Are Biomarkers for Progression in Advanced-Stage Melanoma Patients Receiving Checkpoint Inhibitors
Jesper G Pedersen, Anne Tranberg Madsen, Kristine Raaby Gammelgaard, Ninna Aggerholm Pedersen, Boe Sandahl Sørensen, Trine Heide Øllegaard, Martin R. Jakobsen · 2020 · Cancers
An Update to Hallmarks of Cancer
Swapna Ravi, Antonio Machado Alencar, Jemma Arakelyan, Weihao Xu, Roberta Stauber, Cheng-Chi I Wang, Ruzanna Papyan, Narine A. Ghazaryan, Rosalina M. Pereira · 2022 · Cureus
Biological significance of TERT promoter mutation in papillary urothelial neoplasm of low malignant potential
Chung‐Chieh Wang, Chao‐Yuan Huang, Yu‐Lin Jhuang, C.-Y. Chen, Yung‐Ming Jeng · 2017 · Histopathology
Identification of mechanism of cancer-cell-specific reactivation of hTERT offers therapeutic opportunities for blocking telomerase specifically in human colorectal cancer
Semih Can Akıncılar, Joelle Y.H. Chua, Qin Feng Ng, Claire Hian Tzer Chan, Zahra Eslami‐S, Kaijing Chen, Joo-Leng Low, Surendar Arumugam, Luay Aswad, Clarinda Chua et al. · 2022 · Nucleic Acids Research
Telomerase inhibition is an effective therapeutic strategy in TERT promoter-mutant glioblastoma models with low tumor volume
Elisa Aquilanti, Lauren Kageler, Jacqueline Watson, Duncan M. Baird, Rhiannon E. Jones, Marie Hodges, Zsofia M Szegletes, John G. Doench, Craig A. Strathdee, Jose Ricardo McFaline-Figueroa et al. · 2023 · Neuro-Oncology
Frequent TERT Promoter Mutations in Ocular Surface Squamous Neoplasia
Simone L. Scholz, Henning Thomasen, Henning Reis, Inga Möller, Raid Darawsha, Bettina Müller, Dirk Dekowski, Antje Sucker, Bastian Schilling, Dirk Schadendorf et al. · 2015 · Investigative Ophthalmology & Visual Science
Low frequency of TERT promoter mutations in gastrointestinal stromal tumors (GISTs)
Nathália Cristina Campanella, Ricardo Celestino, Ana Pestana, Cristovam Scapulatempo‐Neto, Antonio Talvane de Oliveira, María José Brito, António Gouveia, José Manuel Lopes, Denise Peixoto Guimarães, Paula Soares et al. · 2014 · European Journal of Human Genetics
Insights about genome function from spatial organization of the genome
Shuvra Shekhar Roy, Ananda Kishore Mukherjee, Shantanu Chowdhury · 2018 · Human Genomics
Substituted Naphthalenediimide Compounds Bind Selectively to Two Human Quadruplex Structures with Parallel Topology
Tam D. Vo, Sally J. Oxenford, Richard M. Angell, Chiara Marchetti, Stephan A. Ohnmacht, W. David Wilson, Stephen Neidle · 2020 · ACS Medicinal Chemistry Letters
HDAC Inhibition Induces PD-L1 Expression in a Novel Anaplastic Thyroid Cancer Cell Line
Luca Hegedüs, Dominika Rittler, Tamás Garay, Paul Stockhammer, Ildikó Kovács, Balázs Döme, Sarah Theurer, Thomas Hager, Thomas Herold, Stavros Kalbourtzis et al. · 2020 · Pathology & Oncology Research
Stem cells for the treatment of glioblastoma: a 20-year perspective
Anda‐Alexandra Calinescu, McKenzie C. Kauss, Zain Sultan, Wajd N. Al‐Holou, Sue O’Shea · 2021 · CNS Oncology
Connecting the dots: Melanoma cell of origin, tumor cell plasticity, trans‐differentiation, and drug resistance
Edgardo Castro‐Pérez, Mithalesh Kumar Singh, Shreyans Sadangi, Carmen Mela‐Sánchez, Vijayasaradhi Setaluri · 2023 · Pigment Cell & Melanoma Research
Absence of Microsatellite Instability In Soft Tissue Sarcomas
Nathália Cristina Campanella, Valter Penna, Guilherme Ribeiro, Lucas Faria Abrahão‐Machado, Cristovam Scapulatempo‐Neto, Rui Manuel Reis · 2015 · Pathobiology
The Genetics of Papillary Microcarcinomas of the Thyroid: Diagnostic and Prognostic Implications
Ana Cunha Rodrigues, Gustavo Penna, Elisabete Rodrigues, Patrícia Castro, Manuel A. Sobrinho-Simões, Paula Soares · 2017 · Current Genomics
Mutation of the TERT promoter leads to poor prognosis of patients with non-small cell lung cancer
Soo-Jung Jung, Dong Sun Kim, Won-Jin Park, Hyunsu Lee, In-Jang Choi, Jae‐Yong Park, Jae‐Ho Lee · 2017 · Oncology Letters
Changes in the clinicopathological characteristics and genetic alterations of follicular thyroid cancer
Young Shin Song, Jung‐Ah Lim, Hye Sook Min, Min Joo Kim, Hoon Sung Choi, Sun Wook Cho, Jae Hoon Moon, Ka Hee Yi, Do Joon Park, Bo Youn Cho et al. · 2017 · European Journal of Endocrinology
The role of telomerase reverse transcriptase (TERT) promoter mutations in prognosis in bladder cancer
Song Wan, Xuan Liu, Wei Hua, Ming Yu Xi, Yulin Zhou, Yueping Wan · 2021 · Bioengineered
Coding Molecular Determinants of Thyroid Cancer Development and Progression
Veronica Valvo, Carmelo Nucera · 2018 · Endocrinology and Metabolism Clinics of North America
Emerging Therapeutic Targets in Chordomas: A Review of the Literature in the Genomic Era
Corey M. Gill, Mary Elizabeth Fowkes, Raj K. Shrivastava · 2019 · Neurosurgery
TERT promoter mutation is an objective clinical marker for disease progression in chondrosarcoma
Yifan Zhang, Yi Chen, Yang Chen, Nelly Seger, Asle Charles Hesla, Panagiotis Tsagkozis, Olle Larsson, Yingbo Lin, Felix Haglund · 2021 · Modern Pathology
Telomerase Activation in Hematological Malignancies
Joana Ropio, Jean‐Philippe Merlio, Paula Soares, Edith Chevret · 2016 · Genes
Association of telomerase reverse transcriptase promoter mutations with clinicopathological features and prognosis of thyroid cancer: a meta-analysis
Xingyun Su, Xiaoxia Jiang, Weibin Wang, Haiyong Wang, Xin Xu, Aihui Lin, Xiaodong Teng, Huiling Wu, Lisong Teng · 2016 · OncoTargets and Therapy
Holmium laser enucleation of the prostate technique for benign prostatic hyperplasia.
Douglas C. Kelly, Akhil Kumar Das · 2012 · PubMed
Proteomic analysis of meningiomas reveals clinically distinct molecular patterns
Michail-Dimitrios Papaioannou, Ugljesa Djuric, Jennifer Kao, Shirin Karimi, Gelareh Mohammed Zadeh, Kenneth Aldape, Phedias Diamandis · 2019 · Neuro-Oncology
Follicular Thyroid Neoplasms
Vincent Cracolici, Lauren L. Ritterhouse, Jeremy P. Segal, Rutika Puranik, Pankhuri Wanjari, Sabah Kadri, Megan Parilla, Nicole A. Cipriani · 2020 · The American Journal of Surgical Pathology
TERT Promoter Mutation C228T Increases Risk for Tumor Recurrence and Death in Head and Neck Cancer Patients
Lídia Maria Rebolho Batista Arantes, Adriana Cruvinel‐Carloni, Ana Carolina de Carvalho, Bruna Pereira Sorroche, André Lopes Carvalho, Cristovam Scapulatempo‐Neto, Rui Manuel Reis · 2020 · Frontiers in Oncology
Whole-genome characterization of lung adenocarcinomas lacking alterations in the RTK/RAS/RAF pathway
Jian Carrot‐Zhang, Xiaotong Yao, Siddhartha H. K. Devarakonda, Aditya S. Deshpande, Jeffrey S. Damrauer, Tiago C. Silva, Christopher K. Wong, Hyo Young Choi, Ina Felau, A. Gordon Robertson et al. · 2021 · Cell Reports
Genomic and epigenomic profile of thyroid cancer
Adrián Acuña-Ruíz, Carlos Carrasco-López, Pilar Santisteban · 2022 · Best Practice & Research Clinical Endocrinology & Metabolism
Telomerase reactivation in cancers: Mechanisms that govern transcriptional activation of the wild-type vs. mutantTERTpromoters
Yinghui Li, Vinay Tergaonkar · 2016 · Transcription
Preoperative Assessment of TERT Promoter Mutation on Thyroid Core Needle Biopsies Supports Diagnosis of Malignancy and Addresses Surgical Strategy
Anna Crescenzi, Pierpaolo Trimboli, Domenico Cicciarella Modica, Chiara Taffon, Leo Guidobaldi, Silvia Taccogna, Alberto Rainer, Marcella Trombetta, Enrico Papini, Giovanni Zelano · 2015 · Hormone and Metabolic Research
Genomic and epigenomic EBF1 alterations modulate TERT expression in gastric cancer
Manjie Xing, Wen Fong Ooi, Jing Ying Tan, Aditi Qamra, Po-Hsien Lee, Zhimei Li, Chang Xu, Nisha Padmanabhan, Jing Quan Lim, Yu Amanda Guo et al. · 2020 · Journal of Clinical Investigation
Pulmonary Fibrosis and a TERT Founder Mutation With a Latency Period of 300 Years
Joanne J. van der Vis, Jasper J. van der Smagt, Frederic A. M. Hennekam, Jan C. Grutters, Coline H.M. van Moorsel · 2020 · CHEST Journal
Telomerase and CD4 T Cell Immunity in Cancer
Magalie Dosset, Andrea Castro, Hannah K. Carter, Maurizio Zanetti · 2020 · Cancers
Genomics and Functional Genomics of Malignant Pleural Mesothelioma
Ece Çakıroğlu, Şerif Şentürk · 2020 · International Journal of Molecular Sciences
Efficacy of a Second Brain Biopsy for Intracranial Lesions after Initial Negativity
Mohamed Chabaane, Aymeric Amelot, Maximilien Riche, Franck Bielle, Karima Mokhtari, Alexandre C. Carpentier, Mehdi Touat, Bertrand Mathon · 2020 · Journal of Clinical Neurology
The landscape and driver potential of site-specific hotspots across cancer genomes
Randi Istrup Juul, Morten Muhlig Nielsen, Malene Juul, Lars Feuerbach, Jakob Skou Pedersen · 2021 · npj Genomic Medicine
The Molecular Interplay between Human Oncoviruses and Telomerase in Cancer Development
Maria Lina Tornesello, Andrea Cerasuolo, Noemy Starita, Anna Lucia Tornesello, Patrizia Bonelli, Franca Maria Tuccillo, Luigi Buonaguro, Maria G. Isaguliants, Franco M. Buonaguro · 2022 · Cancers
TERT Promoter Mutations Enhance Telomerase Activation by Long-Range Chromatin Interactions
Jaewon Min, Jerry W. Shay · 2016 · Cancer Discovery
Regulation of Telomere Homeostasis during Epstein-Barr virus Infection and Immortalization
Siamak A. Kamranvar, Maria Grazia Masucci · 2017 · Viruses
Microfluidic Droplet Digital PCR Is a Powerful Tool for Detection of BRAF and TERT Mutations in Papillary Thyroid Carcinomas
Dorina Ylli, Aneeta D. Patel, Kirk Ernest Jensen, Zhao-Zhang Li, Maria Cecilia Mendonça-Torres, John Costello, Cristiane Jeyce Gomes-Lima, Leonard Wartofsky, Kenneth Dale Burman, Vasyl V. Vasko · 2019 · Cancers
Tumor-Agnostic Circulating Tumor DNA Testing for Monitoring Muscle-Invasive Bladder Cancer
Raquel Carrasco, Mercedes Ingelmo‐Torres, Ramón Trullás, Fiorella L. Roldán, Leonardo Rodríguez‐Carunchio, Lourdes Juez, Joan Sureda, Antonio Alcaraz, Lourdes Mengual, Laura Izquierdo · 2023 · International Journal of Molecular Sciences
Acquired TERT promoter mutations stimulate TERT transcription in mantle cell lymphoma
Julieta Panero, Raquel M. Alves‐Paiva, Alejandro Roisman, Barbara Amelia Aparecida Santana-Lemos, Roberto Passetto Falcão, Gustavo Oliveira, Diego A. Pereira‐Martins, Carmen Stanganelli, Irma Rosa Slavutsky, Rodrigo T. Calado · 2016 · American Journal of Hematology
Oxidative stress and the subcellular localization of the telomerase reverse transcriptase (TERT) in papillary thyroid cancer
Marina Muzza, Carla Colombo, Valentina Cirello, Michela Perrino, Leonardo Vicentini, Laura Fugazzola · 2016 · Molecular and Cellular Endocrinology
Means to the ends: The role of telomeres and telomere processing machinery in metastasis
Nathaniel J Robinson, William P. Schiemann · 2016 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
Association of clinicopathological features and prognosis of TERT alterations in phyllodes tumor of breast
Julia Y. Tsang, Yau-Kam Hui, Michelle A. Lee, Maribel D. Lacambra, Yun‐Bi Ni, Sai‐Yin Cheung, Çherry Wu, Ava Kwong, Gary Man-Kit Tse · 2018 · Scientific Reports
Continuous culture of urine-derived bladder cancer cells for precision medicine
Shuai Jiang, Jiaqi Wang, Yang Chen, Renke Tan, Jun Hou, Yuan Shi, Huihui Zhang, Shiyu Ma, Jianan Wang, Mengmeng Zhang et al. · 2019 · Protein & Cell
OncoCis: annotation of cis- regulatory mutations in cancer
D. S. Perera, Diego Chacon Fajardo, Julie A.I. Thoms, Rebecca C. Poulos, Adam Shlien, Dominik Beck, Peter J. Campbell, John E. Pimanda, Jason W.H. Wong · 2014 · Genome biology
Telomerase reverse transcriptase promoter alterations across cancer types as detected by next‐generation sequencing: A clinical and molecular analysis of 423 patients
Maria Clemence Schwaederle, Nithya Krishnamurthy, Gregory A. Daniels, David Eric Piccioni, Santosh Kesari, Paul Timothy Fanta, Richard B. Schwab, Sandip Pravin Patel, Barbara A. Parker, Razelle Kurzrock · 2017 · Cancer
Telomerase and Telomeres Biology in Thyroid Cancer
Benedetta Donati, Alessia Ciarrocchi · 2019 · International Journal of Molecular Sciences
Classifying Melanoma by TERT Promoter Mutational Status
Michael Shaughnessy, Ching-Ni Jenny Njauw, Mykyta Artomov, Hensin Tsao · 2019 · Journal of Investigative Dermatology
TERT and TERT promoter in melanocytic neoplasms: Current concepts in pathogenesis, diagnosis, and prognosis
Kiran Motaparthi, Jinah Kim, Aleodor A. Andea, Tricia Ann Missall, Roberto A. Novoa, Claudia I. Vidal, Maxwell Alexander Fung, Patrick O. Emanuel · 2020 · Journal of Cutaneous Pathology
Molecular pathogenesis of pediatric thyroid carcinoma
Norisato Mitsutake, Vladimir Saenko · 2020 · Journal of Radiation Research
Urachal cancer—current concepts of a rare cancer
Henning Reis, Tibor Szarvas · 2019 · Der Pathologe
Merkel Cell Polyomavirus Small T Antigen Activates Noncanonical NF-κB Signaling to Promote Tumorigenesis
Jiawei Zhao, Yuemeng Jia, Shunli Shen, Jiwoong Kim, Xun Wang, Eunice Lee, Isaac Brownell, Jeong Hee Cho‐Vega, Cheryl M. Lewis, Jade Homsi et al. · 2020 · Molecular Cancer Research
TERT promoter mutations contribute to adverse clinical outcomes and poor prognosis in radioiodine refractory differentiated thyroid cancer
Gongxun Tan, Bingquan Jin, Xiaoqin Qian, Yuguo Wang, Guoliang Zhang, Enock Adjei Agyekum, Feng Wang, Liang Shi, Yue Zhang, Zhenwei Mao et al. · 2024 · Scientific Reports
Systematic Screening of Promoter Regions Pinpoints Functional Cis -Regulatory Mutations in a Cutaneous Melanoma Genome
Rebecca C. Poulos, Julie A.I. Thoms, Anushi Shah, Dominik Beck, John E. Pimanda, Jason W.H. Wong · 2015 · Molecular Cancer Research
Poorly differentiated and undifferentiated thyroid carcinomas
Catarina Eloy, Luciana Bueno Ferreira, Catarina Salgado, Paula Soares, Manuel A. Sobrinho-Simões · 2015 · Turkish Journal of Pathology
Telomerase: The Devil Inside
Mukesh Kumar, André Lechel, Çagatay Güneş · 2016 · Genes
Molecular Signature of Indeterminate Thyroid Lesions: Current Methods to Improve Fine Needle Aspiration Cytology (FNAC) Diagnosis
Silvia Cantara, Carlotta Marzocchi, Tania Pilli, Sandro Cardinale, Raffaella Forleo, Maria Grazia Castagna, Furio Pacini · 2017 · International Journal of Molecular Sciences
TERT promoter mutations and their correlation with BRAF and RAS mutations in a consecutive cohort of 145 thyroid cancer cases
Andrea Cacciato Insilla, Agnese Proietti, Nicla Borrelli, Elisabetta Macerola, Cristina Niccoli, Paolo Vitti, Paolo Miccoli, Fulvio Basolo · 2017 · Oncology Letters
Noninvasive Analysis of High-Risk Driver Mutations and Gene Expression Profiles in Primary Cutaneous Melanoma
Laura Korb Ferris, Ronald L. Moy, Pedram Gerami, James E. Sligh, Burkhard Jansen, Zuxu Yao, Clay J. Cockerell · 2018 · Journal of Investigative Dermatology